title: [New Oral Anticoagulants During Catheter Ablation of Atrial Fibrillation. Experience With Rivaroxaban].
abstract: Until recently, anticoagulant therapy after catheter ablation of atrial fibrillation, were connected with vitamin K antagonists and drugs of heparin series. New era of novel anticoagulants--dabigatran, rivaroxaban and apixaban is coming up. Our own experience of use in clinical practice of rivoroxaban for patient undergoing catheter ablation of atrial fibrillation will be discussed in this article.
authors.forename: A I
authors.initials: AI
authors.lastname: Kazakov
authors.forename: S M
authors.initials: SM
authors.lastname: Yashin
authors.forename: E V
authors.initials: EV
authors.lastname: Lyan
authors.forename: A V
authors.initials: AV
authors.lastname: Ayrapetyan
mesh_terms: D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D017115:Catheter Ablation / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D065427:Factor Xa Inhibitors / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007430:Intraoperative Care / Q000379:methods*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000069552:Rivaroxaban / Q000008:administration & dosage*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D065427:Factor Xa Inhibitors; D000069552:Rivaroxaban